Bio-Rad Laboratories, Inc. (BIO)
Chart Events
Performance Outlook
| Previous Close | 566.87 |
| Open | 563.39 |
| Bid | 564.15 x 800 |
| Ask | 566.25 x 800 |
| Day's Range | 553.02 - 573.92 |
| 52 Week Range | 309.38 - 689.00 |
| Volume | 179,275 |
| Avg. Volume | 234,180 |
| Market Cap | 16.84B |
| Beta (5Y Monthly) | 0.80 |
| PE Ratio (TTM) | 4.46 |
| EPS (TTM) | 126.20 |
| Earnings Date | May 04, 2021 - May 10, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 752.50 |
- Investopedia
Top Healthcare Stocks for March 2021
These are the healthcare stocks with the best value, fastest growth, and most momentum for March 2021.
- Investopedia
Top Stocks for March 2021
The Russell 1000 Index is a market-capitalization-weighted index of the 1000 largest publicly traded companies in the U.S. It represents approximately 92% of the total market capitalization of all listed stocks in the U.S. equity market. Value investing is a factor-based investing strategy in which you pick stocks that you believe are trading for less than what they are intrinsically worth, usually by measuring the ratio of the stock's price to one or more fundamental business metrics. A widely accepted value metric is the price-to-earnings ratio (P/E Ratio).
- Business Wire
Bio-Rad to Participate in Citi’s 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive Vice President and COO; and Ilan Daskal, Executive Vice President and CFO will participate virtually in a Fireside Chat at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference on Wednesday, February 24, at 11:25 AM (PST).
